X0202 4 2007-02-26 0001003124 PHARMACEUTICAL PRODUCT DEVELOPMENT INC PPDI 0001033409 ESHELMAN FREDRIC N 6814 TOWLES ROAD WILMINGTON NC 28409 1 1 0 0 CEO Common Stock 2007-02-26 4 S 0 1300 33.31 D 9189460 D Common Stock 2007-02-26 4 S 0 488 33.32 D 9188972 D Common Stock 2007-02-26 4 S 0 1312 33.33 D 9187660 D Common Stock 2007-02-26 4 S 0 588 33.34 D 9187072 D Common Stock 2007-02-26 4 S 0 512 33.35 D 9186560 D Common Stock 2007-02-26 4 S 0 300 33.36 D 9186260 D Common Stock 2007-02-26 4 S 0 184 33.37 D 9186076 D Common Stock 2007-02-26 4 S 0 16 33.38 D 9186060 D Common Stock 2007-02-26 4 S 0 200 33.39 D 9185860 D Common Stock 2007-02-26 4 S 0 100 33.40 D 9185760 D Common Stock 2007-02-26 4 S 0 100 33.41 D 9185660 D Common Stock 2007-02-26 4 S 0 100 33.45 D 9185560 D Common Stock 2007-02-26 4 S 0 100 33.46 D 9185460 D Common Stock 2007-02-26 4 S 0 100 33.47 D 9185360 D Common Stock 2007-02-26 4 S 0 100 33.55 D 9185260 D Common Stock 2007-02-26 4 S 0 100 33.60 D 9185160 D Common Stock 2007-02-26 4 S 0 100 33.66 D 9185060 D Common Stock 2007-02-26 4 S 0 600 33.67 D 9184460 D Common Stock 2007-02-26 4 S 0 192 33.68 D 9184268 D Common Stock 2007-02-26 4 S 0 8 33.70 D 9184260 D Common Stock 2007-02-26 4 S 0 200 33.71 D 9184060 D Common Stock 2007-02-26 4 S 0 100 33.72 D 9183960 D This Form 4 is 3 of 3 Forms 4 being filed to report the sale of stock on February 26, 2007 pursuant to the 10b5-1 trading plan adopted by the Reporting Person. Lisa C. Noecker attorney-in-fact for Fred N. Eshelman 2007-02-27